Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine
Conditions:   Norwalk Gastroenteritis;   Norovirus Infections Interventions:   Biological: Norovirus Bivalent (GI.1 / GII.4) Vaccine（low）;   Biological: Norovirus Bivalent (GI.1 / GII.4) Vaccine（middle）;   Biological: Norovirus Bivalent (GI.1 / GII.4) Vaccine（high）;   Biological: Normal saline;   Biological: Aluminum adjuvant Sponsors:   National Vaccine and Serum Institute, China;   Lanzhou Institute of Biological Products Co., Ltd;   Beijing Zhong Sheng Heng Yi Pharmaceutical Technology Co., Ltd.;   Zhengzhou University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2019 Category: Research Source Type: clinical trials